Skip to main content
Livermore
Livermore
ZHEN

Davenport & Co LLC

SEC CIK
0000887777
Latest filing
Jul 13, 2026

GSK holding history

GSK plc in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
15,656
Value
$820.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Davenport & Co LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,656$820.7K<0.1%−1,123−6.7%ReducedHolders
Q1 202616,779$926.0K<0.1%−74,432−81.6%ReducedHolders
Q4 202591,211$4.47M<0.1%−17,430−16.0%ReducedHolders
Q3 2025108,641$4.69M<0.1%+4,573+4.4%AddedHolders
Q2 2025104,068$4.00M<0.1%+87,412+524.8%AddedHolders
Q1 202516,656$645.3K<0.1%−668−3.9%ReducedHolders
Q4 202417,324$585.8K<0.1%−723−4.0%ReducedHolders
Q3 202418,047$737.7K<0.1%−1,009−5.3%ReducedHolders
Q2 202419,056$733.7K<0.1%−8,699−31.3%ReducedHolders
Q1 202427,755$1.19M<0.1%−3,767−12.0%ReducedHolders
Q4 202331,522$1.17M<0.1%−343−1.1%ReducedHolders
Q3 202331,865$1.16M<0.1%−1,829−5.4%ReducedHolders
Q2 202333,694$1.20M<0.1%+4,833+16.7%AddedHolders
Q1 202328,861$1.03M<0.1%−2,016−6.5%ReducedHolders
Q4 202230,877$1.08M<0.1%+3,084+11.1%AddedHolders
Q3 202227,793$818.0K<0.1%−12,802−31.5%ReducedHolders
Q2 202240,595$1.77M<0.1%+4,617+12.8%AddedHolders
Q1 202235,978$1.57M<0.1%+1,065+3.1%AddedHolders
Q4 202134,913$1.54M<0.1%+1,274+3.8%AddedHolders
Q3 202133,639$1.28M<0.1%+1,319+4.1%AddedHolders
Q2 202132,320$1.29M<0.1%+2,818+9.6%AddedHolders
Q1 202129,502$1.05M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.